Skip to content

CPAP Device In-lab Assessment NZ

CPAP Device In-lab Assessment NZ

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02948010
Enrollment
104
Registered
2016-10-28
Start date
2016-11-30
Completion date
2017-03-31
Last updated
2017-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Brief summary

The purpose of this trial is to assess device performance against participants in an overnight study to ensure the product meets user and clinical requirements

Detailed description

Existing Adult Continuous Positive Airway Pressure (CPAP) therapy users will be recruited for an overnight polysomnography (PSG) sleep study. The participants will use the investigational CPAP device and be connected to a PSG during their session. The device performance during the session will be assessed. Outcomes of the clinical investigation include downloadable device data reports, device error reports and participants perception questionnaires and PSG data.

Interventions

DEVICEAuto CPAP + comfort feature A

Auto CPAP + comfort feature A using Fisher & Paykel Healthcare CPAP Device

DEVICEAuto CPAP with comfort feature B

Auto CPAP with comfort feature B using Fisher & Paykel Healthcare CPAP Device

DEVICEAuto CPAP with no comfort feature

Auto CPAP with no comfort feature using Fisher & Paykel Healthcare CPAP Device

DEVICEAuto CPAP with comfort feature A+B

Auto CPAP with comfort feature A+B using Fisher & Paykel Healthcare CPAP Device

DEVICECPAP with comfort feature A

CPAP with comfort feature A using Fisher & Paykel Healthcare CPAP Device

DEVICECPAP with comfort feature B

CPAP with comfort feature B using Fisher & Paykel Healthcare CPAP Device

DEVICECPAP with no comfort feature

CPAP with no comfort feature using Fisher & Paykel Healthcare CPAP Device

DEVICECPAP with comfort feature A + B

CPAP with comfort feature A + B using Fisher & Paykel Healthcare CPAP Device

DEVICECPAP at Sub therapeutic level

CPAP at Sub therapeutic level using Fisher & Paykel Healthcare CPAP Device

Sponsors

Fisher and Paykel Healthcare
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years or older * Diagnosed with OSA by a practicing physician and prescribed PAP therapy (fixed or auto CPAP) * Fluent in spoken and written English.

Exclusion criteria

* Be contraindicated for PAP (fixed or auto CPAP) therapy. * Have another significant sleep disorder(s) (e.g. periodic leg movements or insomnia). * Have obesity hypoventilation syndrome or congestive heart failure. * Require supplemental oxygen with your PAP (fixed or auto CPAP) device. * Have any implanted electronic medical devices (e.g. cardiac pacemakers). * Be pregnant or think they might be pregnant.

Design outcomes

Primary

MeasureTime frameDescription
Apnea Hypopnea Index (AHI) (i.e. number of events/hour).4 monthsObtained from device and PSG data
Log of safety-related events, measured as number of safety-related faults4 monthsObtained from device
Machine reported faults, measured as number of machine faults4 monthsObtained from device

Secondary

MeasureTime frameDescription
Participant perception of the device, as determined by the questionnaire responses4 monthsObtained through user questionnaire

Countries

New Zealand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026